Quercetin blocks airway epithelial cell chemokine expression

American Journal of Respiratory Cell and Molecular Biology

Volumn 35, Issue 5, 2006, Pages 602-610

  Nanua, Suparna ^b   Zick, Suzanna M ^b   Andrade, Juan E ^b   Sajjan, Umadevi S ^b   Burgess, John R ^b   Lukacs, Nicholas W ^b   Hershenson, Marc B ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE

Author keywords

Asthma; Chemokines; Epithelial cells; Lung; Signal transduction

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CHEMOKINE; DACTINOMYCIN; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; QUERCETIN; RNA; TUMOR NECROSIS FACTOR ALPHA;

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; COCKROACH; ENZYME ASSAY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; REPORTER GENE; SENSITIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ALLERGENS; ANIMALS; ANTIOXIDANTS; BRONCHIAL PROVOCATION TESTS; CELLS, CULTURED; CHEMOKINE CCL2; CHROMONES; COCKROACHES; ENZYME INHIBITORS; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; MICE; MICE, INBRED BALB C; MORPHOLINES; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN; REACTIVE OXYGEN SPECIES; RESPIRATORY MUCOSA; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

BLATTARIA; EUKARYOTA;

EID: 33750696045     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2006-0149OC     Document Type: Article

References (49)

1. National Toxicology Program. Toxicology and carcinogenesis studies of quercetin (CAS No. 117-39-5) in F344 rats (feed studies). Natl Toxicol Program Tech Rep Ser 1992;409:1-171.
2. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000;351:95-105.
3. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Remesy C, Chap H, Payrastre B. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 1997;53:1649-1657.
4. Huang Y-T, Hwang J-J, Lee P-P, Ke F-C, Huang J-H, Huang C-J, Kandaswami C, Middleton E Jr, Lee M-T. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol 1999;128:999-1010.
5. Peet GW, Li J. IkappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin. J Biol Chem 1999;274:32655-32661.
6. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 1994;269:5241-5248.
7. Wadsworth TL, Koop DR. Effects oi the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 1999;57:941-949.
8. Wadsworth TL, McDonald TL, Koop DR. Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-α. Biochem Pharmacol 2001;62:963-974.
9. Xagorari A, Papapetropoulos A, Mauromatis A, Economou M, Fotsis T, Roussos C. Luteolin inhibits an endotoxin-stimulated phosphorylation cascade and proinflammatory cytokine production in macrophages. J Pharmacol Exp Ther 2001;296:181-187.
10. Cho SY, Park SJ, Kwon MJ, Jeong TS, Bok SH, Choi WY, Jeong WI, Ryu SY, Do SH, Lee CS, et al. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 2003;243:153-160.
11. Mu MM, Chakravortty D, Sugiyama T, Koide N, Takahashi K, Mori I, Yoshida T, Yokochi T. The inhibitory action oi quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells. J Endotoxin Res 2001;7:431-438.
12. Fox CC, Wolf EJ, Kagey-Sobotka A, Lichtenstein LM. Comparison of human lung and intestinal mast cells. J Allergy Clin Immunol 1988;81:89-94.
13. Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy 2000;30:501-508.
14. Kempuraj D, Madhappan B, Christodoulou S, Boucher W, Cao J, Papadopoulou N, Cetrulo CL, Theoharides TC. Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C theta phosphorylation in human mast cells. Br J Pharmacol 2005;145:934-944.
15. Sato M, Miyazaki T, Kambe F, Maeda K, Seo H. Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 1997;24:1680-1684.
16. Deiana M, Assunta Dessi M, Ke B, Liang Y-F, Higa T, Gilmour PS, Jen L-S, Rahman I, Aruoma OI. The antioxidant cocktail effective microorganism X (EM-X) inhibits oxidant-induced interleukin-8 release and the peroxidation of phospholipids in vitro. Biochem Biophys Res Commun 2002;296:1148-1151.
17. Gunn M, Nelken N, Liao X, Williams L. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J Immunol 1997;158:376-383.
18. Ackerman V, Marini M, Vittori E, Bellini A, Vassali G, Mattoli S. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: relationship to atopic status, symptoms, and level of airway hyperresponsiveness. Chest 1994;105:687-696.
19. Tillie-Leblond I, Pugin J, Marquette C-H, Lamblin C, Saulnier F, Brichet A, Wallaert B, Tonnel A-B, Gosset P. Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus. Am J Respir Crit Care Med 1999;159:487-494.
20. Lamblin C, Gosset P, Tillie-Leblond I, Saulnier F, Marquette CH, Wallaert B, Tonnel AB. Bronchial neutrophilia in patients with non-infectious status asthmaticus. Am J Respir Crit Care Med 1998;157:394-402.
21. Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Bjornsson E, Roomans GM, Boman G, Seveus L, Venge P. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. Am J Respir Crit Care Med 2000;162:2295-2301.
22. Alam R, York J, Boyars M, Stafford S, Grant JA, Lee J, Forsythe P, Sim T, Ida N. Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients. Am J Respir Crit Care Med 1996;153:1398-1404.
23. Jahnz-Rozyk KM, Kuna P, Pirozynska E. Monocyte chemotactic and activating factor/monocyte chemoattractant protein (MCAF/MCP-1) in bronchoalveolar lavage fluid from patients with atopic asthma and chronic bronchitis. J Investig Allergol Clin Immunol 1997;7:254-259.
24. Sajjan U, Keshavjee S, Forstner J. Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect Immun 2004;72:4188-4199.
25. Li J, Johnson XD, Iazvovskaia S, Tan A, Lin A, Hershenson MB. Signaling intermediates required for NF-kappa B activation and IL-8 expression in CF bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol 2003;284:L307-L315.
26. Casola A, Garofalo RP, Jamaluddin M, Vlahopoulos S, Brasier AR. Requirement of a novel upstream response element in respiratory syncytial virus-induced IL-8 gene expression. J Immunol 2000;164:5944-5951.
27. Campbell EM, Kunkel SL, Strieter RM, Lukacs NW. Temporal role of chemokines in a murine model of cockroach allergen-induced airway hyperreactivity and eosinophilia. J Immunol 1998;161:7047-7053.
28. Campbell EM, Charo IF, Kunkel SL, Strieter RM, Boring L, Gosling J, Lukacs NW. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/-mice: the role of mast cells. J Immunol 1999;163:2160-2167.
29. Erlund I, Meririnne E, Alfthan G, Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 2001;131:235-241.
30. Mullen W, Graf BA, Caldwell ST, Hartley RC, Duthie GG, Edwards CA, Lean ME, Crozier A. Determination of flavonol metabolites in plasma and tissues of rats by HPLC-radiocounting and tandem mass spectrometry following oral ingestion of [2-(14)C]quercetin-4'-glucoside. J Agric Food Chem 2002;50:6902-6909.
31. Radeke H, Cross A, Hancock J, Jones O, Nakamura M, Kaever V, Resch K. Functional expression of NADPH oxidase components (alpha- and beta-subunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. J Biol Chem 1991;266:21025-21029.
32. Wennstrom S, Hawkins P, Cooke F, Hara K, Yonesawa K, Kasuga M, Jackson T, Claesson-Welsh L, Stephens L. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol 1994;4:385-393.
33. Hawkins PT, Eguinoa A, Qiu R-G, Stokoe D, Cooke FT, Walters R, Wennstrom S, Claesson-Welsh L, Evans T, Symons M, et al. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr Biol 1995;5:393-403.
34. Abo A, Pick E, Hall A, Totty N, Teahan CG, Segal AW. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 1991;353:668-670.
35. Beraud C, Henzel WJ, Baeuerle PA. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappa B activation. Proc Natl Acad Sci USA 1999;96:429-434.
36. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, Donner DB. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999;401:82-85.
37. Romashkova JA, Makarov SS. NF-kappaB is a target of Akt in antiapoptotic PDGF signalling. Nature 1999;401:86-90.
38. Sizemore N, Leung S, Stark GR. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappa B p65/RelA subunit. Mol Cell Biol 1999;19:4798-4805.
39. Reddy SAG, Huang JH, Liao WS-L. Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-κB activation. J Immunol 2000;164:1355-1363.
40. Madrid LV, Wang C-Y, Guttridge DC, Schottelius AJG, Baldwin AS Jr, Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappa B. Mol Cell Biol 2000;20:1626-1638.
41. Madrid LV, Mayo MW, Reuther JY, Baldwin AS Jr. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-kappa B through utilization of the I kappa B kinase and activation of the mitogen-activated protein kinase p38. J Biol Chem 2001;276:18934-18940.
42. Kimball SR, Heinzinger NK, Horetsky RL, Jefferson LS. Identification of interprotein interactions between the subunits of eukaryotic initiation factors eIF2 and eIF2B. J Biol Chem 1998;273:3039-3044.
43. Ito T, Warnken SP, May WS. Protein synthesis inhibition by flavonoids: Roles of eukaryotic initiation factor 2α kinases. Biochem Biophys Res Commun 1999;265:589-594.
44. Chang RC-C, Suen K-C, Ma C-H, Elyaman W, Ng H-K, Hugon J. Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2α; in neuronal degeneration. J Neurochem 2002;83:1215-1225.
45. Ko WC, Shih CM, Chen MC, Lai YH, Chen JH, Chen CM, Lin CN. Suppressive effects of 3-O-methylquercetin on ovalbumin-induced airway hyperresponsiveness. Planta Med 2004;70:1123-1127.
46. Shoskes DA, Zeitlin SI, Shahed A, Rajfer J. Quercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial. Urology 1999;54:960-963.
47. Hollman PC, van Trijp JM, Mengelers MJ, de Vries JH, Katan MB. Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett 1997;114:139-140.
48. Raju TAN, Lakshmi ANV, Anand T, Rao LV, Sharma G. Protective effects of quercetin during influenza virus-induced oxidative stress. Asia Pac J Clin Nutr 2000;9:314-317.
49. Kumar P, Sharma S, Khanna M, Raj HG. Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection. Int J Exp Pathol 2003;84:127-133.